It appears reasonable to improve physician-patient communication and broaden consideration of patients' needs, which suggests a direction for further studies on the role of routine 25(OH)D testing in the standard care of patients with breast and prostate cancer.
Mikołajczyk et al. (Wed,) studied this question.